Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in the U.S.

The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have ...

A modified FLOT regimen (fluorouracil, oxaliplatin, and docetaxel; TFOX) outperformed a standard chemotherapy triplet for the ...

“She’s an example of this emerging face of cancer that's really quite challenging and quite alarming,” Deignan said.

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have discovered that expansion of mutant blood cells, a phenomenon linked to aging, ...

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have discovered that expansion of ...

A new study points to a bacterial toxin as fueling a rise in early-onset colorectal cancer cases. But what is this toxin—and ...

Suleika Jaouad’s new book provides a master class in personal writing. Here’s why it’s a worthwhile habit — for everyone, not ...

Researchers have discovered that expansion of mutant blood cells, a phenomenon linked to ageing, can be found in cancerous ...

South Carolina lacks a top-tier cancer center, but MUSC is planning to reach that status in coming years and is now pursuing ...